Dataminers Find Five Possible DLC Characters in Marvel Tokon: Fighting Souls

Marvel Tokon: Fighting Souls has barely settled into players' libraries and the dataminers are already making headlines. Arc System Works' latest fighter launched on PC to a rocky start — stuttering issues plagued the initial release — but a swift patch turned sentiment around quickly. Now the conversation has shifted from performance to what comes next, as dataminers dig through the game's files and surface five character names that could signal the future of the roster.

The stakes are clear: fighting games depend on solid post‑launch support, and Marvel Tokon is up against Marvel Rivals, which already dominates the scene. Gamers who want to know if Tokon’s upcoming DLC will really set it apart need to pay attention. The leaked roster—Doctor Strange, Wasp, Gambit, The Thing, and Daredevil—spawns instant debate over how much overlap there’s with existing titles. Fans have been keeping the conversation alive, and the chatter is intense. If you’re hunting for fresh characters, these names might just tip the scales.

The Context

Arc System Works has built a reputation for clean data hygiene in recent years, and dataminer Ryn confirmed that trend holds here. "btw, there's not much to datamine out of tokon for unreleased content (thank god). arcsys has gotten really good about cleaning up in the last few years," they posted on social media. That cleanup effort may have contributed to the PC stuttering at launch — many players blamed aggressive anti-datamining measures for the performance issues — but the fix arrived quickly and the game now runs as intended. Ryn did find one thing worth noting: battle pass assets, with a blunt warning to "get ready lol" for what that entails.

Meanwhile, notable datamining group X0XLEAK surfaced the five character names during their own excavation. Their post explicitly labeled these as "possible prototype/future characters" that are "subject to change," which tempers expectations appropriately. These are not background NPCs or stage cameos — the phrasing suggests actual playable implementations, whether as prototypes or planned DLC. The distinction matters because Tokon's stages already feature non-playable Marvel heroes as environmental flavor; these five names appear in a different category entirely.

The only officially confirmed DLC character remains Phoenix Cyclops, announced during a San Diego Comic Con panel for a Fall 2026 release. He will lead a team whose other members have not been revealed, though Phoenix Force connections seem probable. That announcement gives players a concrete timeline for the first post-launch addition, while the datamined five remain in speculative territory.

The Case For Differentiation

The community reaction has been heated, and the core argument is simple: four of the five datamined characters already appear in Marvel Rivals. Doctor Strange, Gambit, The Thing, and Daredevil are all playable in NetEase's hero shooter, leaving Wasp as the only name not currently on that roster. For a fighting game trying to carve out its own identity, that overlap looks problematic on paper. Players on social media have argued that the only truly unique addition here is Wasp, and the sentiment reflects a genuine concern about roster distinctiveness in a shared IP space.

But roster overlap tells only half the story. Tokon and Rivals differ fundamentally in genre — fighting game versus hero shooter — and that changes how characters function mechanically. Doctor Strange in a 2D fighter built by Arc System Works plays nothing like Doctor Strange in a third-person team shooter. The studio's pedigree with Guilty Gear and Dragon Ball FighterZ suggests deep, technical movesets that reward lab time and matchup knowledge, a completely different design language from Rivals' ability-cooldown framework. The Thing's grappler archetype in a traditional fighter offers a distinct experience from his tank role in a hero shooter. Genre context matters more than character name overlap.

Tokon also boasts roster picks that Rivals does not. Carnage, Doctor Doom, and Green Goblin give the fighter a villain variety that the shooter has yet to match, and Danger — a deep-cut mutant — makes her first-ever fully playable video game appearance here. These choices signal a different curatorial philosophy: Tokon leans into fighting game archetypes (rushdown, zoning, grappler) mapped onto Marvel characters, while Rivals balances around team composition and objective play. The same character name can serve two very different mechanical purposes.

The Counter-Argument

Fair point: perception drives player retention as much as mechanical reality. If the average player sees "Doctor Strange, Gambit, The Thing, Daredevil" and thinks "I already play these in Rivals," the marketing battle is already uphill. Fighting games rely on a dedicated core, but they also need a steady influx of casual players to keep matchmaking healthy. Roster familiarity can breed contempt just as easily as comfort. Arc System Works will need to communicate how these characters differ in Tokon — not just that they do — through trailers, breakdowns, and hands-on events that showcase the fighting-game-specific toolkits.

The "prototype" label from X0XLEAK also introduces uncertainty. These five names might represent early exploration that never ships, or they could be locked-in DLC plans. The battle pass assets Ryn found suggest a structured post-launch content pipeline, but the character roster attached to it remains unconfirmed. Phoenix Cyclops arriving in Fall 2026 gives a hard date for the first addition; everything else is speculation until Arc System Works makes it official.

For now, Marvel Tokon: Fighting Souls sits at a 9 out of 10 from IGN — a glowing review that validates the core fighting experience. The PC stuttering is fixed. Phoenix Cyclops has a release window. The datamined five exist in a Schrödinger's state of maybe-DLC, maybe-prototypes, maybe-nothing. What happens next depends on whether Arc System Works can turn mechanical differentiation into a marketing narrative that convinces players this roster deserves a second home alongside Rivals. The tools are there. The question is whether the message lands.